Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bad Neustadt A.D.Saale

6 clinical trials in Bad Neustadt A.D.Saale, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bad Neustadt A.D.Saale at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Bad Neustadt A.D.Saale

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Insel Gruppe AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Flecainide Acetate
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:SOVATELTIDE
  • Sponsor:Pharmazz EU Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Technische Universitaet Dresden

Ischaemic stroke+2

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Bad Neustadt A.D.Saale

What the registry says about research in the country

01 Stroke Prevention and Treatment

Innovative research focusing on acute cerebral ischemic stroke treatments, evaluating new therapeutic approaches to improve patient outcomes and recovery.

  • Acute Stroke Management
  • Prevention Strategies
  • Functional Recovery Assessment

Studies are evaluating novel compounds including sovateltide to enhance post-stroke functional outcomes.

02 Advanced Stroke Therapeutics

Groundbreaking trials examining FXIa inhibitor therapy in combination with antiplatelet treatments for patients who have experienced stroke or transient ischemic attacks.

  • Secondary Stroke Prevention
  • Blood Clot Prevention
  • Safety Monitoring

Research focuses on reducing recurrent stroke risk while maintaining optimal safety profiles.

03 Innovative Stroke Interventions

Clinical investigations of milvexian and its potential in preventing subsequent strokes in high-risk patients following acute ischemic events.

  • Risk Reduction Strategies
  • Post-Stroke Care
  • Treatment Efficacy

These studies aim to establish new standards in stroke prevention and management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.